These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 27609071)

  • 21. Quantifying regional α -synuclein, amyloid β, and tau accumulation in lewy body dementia.
    Miller RL; Dhavale DD; O'Shea JY; Andruska KM; Liu J; Franklin EE; Buddhala C; Loftin SK; Cirrito JR; Perrin RJ; Cairns NJ; Campbell MC; Perlmutter JS; Kotzbauer PT
    Ann Clin Transl Neurol; 2022 Feb; 9(2):106-121. PubMed ID: 35060360
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cortical Lewy bodies and Aβ burden are associated with prevalence and timing of dementia in Lewy body diseases.
    Ruffmann C; Calboli FC; Bravi I; Gveric D; Curry LK; de Smith A; Pavlou S; Buxton JL; Blakemore AI; Takousis P; Molloy S; Piccini P; Dexter DT; Roncaroli F; Gentleman SM; Middleton LT
    Neuropathol Appl Neurobiol; 2016 Aug; 42(5):436-50. PubMed ID: 26527105
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cognitive and Pathological Influences of Tau Pathology in Lewy Body Disorders.
    Coughlin D; Xie SX; Liang M; Williams A; Peterson C; Weintraub D; McMillan CT; Wolk DA; Akhtar RS; Hurtig HI; Branch Coslett H; Hamilton RH; Siderowf AD; Duda JE; Rascovsky K; Lee EB; Lee VM; Grossman M; Trojanowski JQ; Irwin DJ
    Ann Neurol; 2019 Feb; 85(2):259-271. PubMed ID: 30549331
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical correlates of pathology in the claustrum in Parkinson's disease and dementia with Lewy bodies.
    Kalaitzakis ME; Pearce RK; Gentleman SM
    Neurosci Lett; 2009 Sep; 461(1):12-5. PubMed ID: 19523504
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Staging of cytoskeletal and beta-amyloid changes in human isocortex reveals biphasic synaptic protein response during progression of Alzheimer's disease.
    Mukaetova-Ladinska EB; Garcia-Siera F; Hurt J; Gertz HJ; Xuereb JH; Hills R; Brayne C; Huppert FA; Paykel ES; McGee M; Jakes R; Honer WG; Harrington CR; Wischik CM
    Am J Pathol; 2000 Aug; 157(2):623-36. PubMed ID: 10934165
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structural Insights into the Altering Function of CRMP2 by Phosphorylation.
    Sumi T; Imasaki T; Aoki M; Sakai N; Nitta E; Shirouzu M; Nitta R
    Cell Struct Funct; 2018; 43(1):15-23. PubMed ID: 29479005
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Significant Overlap of α-Synuclein, Amyloid-β, and Phospho-Tau Pathologies in Neuropathological Diagnosis of Lewy-related Pathology: Evidence from China Human Brain Bank.
    Cong C; Zhang W; Qian X; Qiu W; Ma C
    J Alzheimers Dis; 2021; 80(1):447-458. PubMed ID: 33554920
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Changes in the expression of collapsin response mediator protein-2 during synaptic plasticity in the mouse hippocampus.
    Kadoyama K; Matsuura K; Nakamura-Hirota T; Takano M; Otani M; Matsuyama S
    J Neurosci Res; 2015 Nov; 93(11):1684-92. PubMed ID: 26250894
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human amyloid beta and α-synuclein co-expression in neurons impair behavior and recapitulate features for Lewy body dementia in Caenorhabditis elegans.
    Huang X; Wang C; Chen L; Zhang T; Leung KL; Wong G
    Biochim Biophys Acta Mol Basis Dis; 2021 Oct; 1867(10):166203. PubMed ID: 34146705
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Colocalization of phosphorylated forms of WAVE1, CRMP2, and tau in Alzheimer's disease model mice: Involvement of Cdk5 phosphorylation and the effect of ATRA treatment.
    Watamura N; Toba J; Yoshii A; Nikkuni M; Ohshima T
    J Neurosci Res; 2016 Jan; 94(1):15-26. PubMed ID: 26400044
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Decreased immunoreactivities of neocortical AMPA receptor subunits correlate with motor disability in Lewy body dementias.
    Mohamed NE; Howlett DR; Ma L; Francis PT; Aarsland D; Ballard CG; McKeith IG; Chen CP; Lai MK
    J Neural Transm (Vienna); 2014 Jan; 121(1):71-8. PubMed ID: 23846847
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cycles of aberrant synaptic sprouting and neurodegeneration in Alzheimer's and dementia with Lewy bodies.
    Hashimoto M; Masliah E
    Neurochem Res; 2003 Nov; 28(11):1743-56. PubMed ID: 14584828
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Are dementia with Lewy bodies and Parkinson's disease dementia the same disease?
    Jellinger KA; Korczyn AD
    BMC Med; 2018 Mar; 16(1):34. PubMed ID: 29510692
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessment of ZnT3 and PSD95 protein levels in Lewy body dementias and Alzheimer's disease: association with cognitive impairment.
    Whitfield DR; Vallortigara J; Alghamdi A; Howlett D; Hortobágyi T; Johnson M; Attems J; Newhouse S; Ballard C; Thomas AJ; O'Brien JT; Aarsland D; Francis PT
    Neurobiol Aging; 2014 Dec; 35(12):2836-2844. PubMed ID: 25104558
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Striatal β-amyloid in dementia with Lewy bodies but not Parkinson's disease.
    Halliday GM; Song YJ; Harding AJ
    J Neural Transm (Vienna); 2011 May; 118(5):713-9. PubMed ID: 21479514
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CRMP2-derived peptide ST2-104 (R9-CBD3) protects SH-SY5Y neuroblastoma cells against Aβ
    Ji Y; Hu Y; Ren J; Khanna R; Yao Y; Chen Y; Li Q; Sun L
    Chem Biol Interact; 2019 May; 305():28-39. PubMed ID: 30871964
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Confluence of α-synuclein, tau, and β-amyloid pathologies in dementia with Lewy bodies.
    Colom-Cadena M; Gelpi E; Charif S; Belbin O; Blesa R; Martí MJ; Clarimón J; Lleó A
    J Neuropathol Exp Neurol; 2013 Dec; 72(12):1203-12. PubMed ID: 24226269
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Degeneration of dopaminergic circuitry influences depressive symptoms in Lewy body disorders.
    Patterson L; Rushton SP; Attems J; Thomas AJ; Morris CM
    Brain Pathol; 2019 Jul; 29(4):544-557. PubMed ID: 30582885
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical and biochemical correlates of insoluble alpha-synuclein in dementia with Lewy bodies.
    Klucken J; Ingelsson M; Shin Y; Irizarry MC; Hedley-Whyte ET; Frosch M; Growdon J; McLean P; Hyman BT
    Acta Neuropathol; 2006 Feb; 111(2):101-8. PubMed ID: 16482476
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dementia with Lewy bodies and Parkinson's disease-dementia: current concepts and controversies.
    Jellinger KA
    J Neural Transm (Vienna); 2018 Apr; 125(4):615-650. PubMed ID: 29222591
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.